Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Danijela Karalic"'
Publikováno v:
Journal of NeuroVirology. 24:305-313
In immunocompromised individuals, especially in patients with T cell immunodeficiency, reactivation of JCPyV can cause serious life-threatening diseases. Nowadays, HIV infection is one of the most important factor for reactivation of JCPyV and the de
Autor:
Natasa Katanic, Sonja Pavlovic, Jelena Nestorov, Jelena Jordovic, Danijela Karalic, Ksenija Bojovic, Nikola Kotur, Ivana Lazarevic, Dragan Delic, Branka Zukic, Vladimir Gasic, Aleksandar Urošević, Nataša Nikolić, Jasmina Simonovic-Babic
Publikováno v:
Journal of infection in developing countries. 13(6)
Introduction: Patients with severe fibrosis or cirrhosis are at high risk for liver-related complications, even after successful antiviral treatment and/or regression of fibrosis. These are the first published results concerning the role of IL-28B ge
Autor:
Tanja Jovanovic, Jovica Milovanovic, Maja Cupic, Goran Stevanovic, Bojan Banko, Andja Cirkovic, Ana Banko, Ivana Lazarevic, Danijela Karalic
Publikováno v:
Journal of Medical Biochemistry, Vol 35, Iss 3, Pp 337-346 (2016)
Journal of Medical Biochemistry (2016) 35(3):337-346
Journal of Medical Biochemistry
Journal of Medical Biochemistry (2016) 35(3):337-346
Journal of Medical Biochemistry
Primary Epstein-Barr virus (EBV) infection is usually asymptomatic, although at times it results in the benign lymphoproliferative disease, infectious mononucleosis (IM), during which almost half of patients develop hepatitis. The aims of the present
Autor:
Miroslav Andric, Danijela Karalic, Aleksandra Knezevic, Jelena Milasin, Ivan Soldatovic, Nadja Nikolic, Aleksandar Jakovljevic
Publikováno v:
Journal of Endodontics
Introduction Different genotypes of human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) possess specific pathogenic abilities because of various interactions with the host's immune system and differences in cell tropism. The aim of this study w
Autor:
Maja Cupic, Vojko Djukic, Ivana Lazarevic, Ana Banko, Danijela Karalic, Tanja Jovanovic, Goran Stevanovic
Publikováno v:
Medical microbiology and immunology. 208(1)
Epstein–Barr virus (EBV) has been identified as a group 1 carcinogenic agent, particularly for nasopharyngeal carcinoma (NPC). The sequence diversity of EBV nuclear antigen 1 (EBNA1) reflects region-restricted polymorphisms, which may be associated
Autor:
Ivana Lazarevic, Danijela Karalic
Publikováno v:
Medicinski Podmladak, Vol 66, Iss 2, Pp 31-35 (2015)
Human polyomaviruses, BK virus (BKV) and JC virus (JCV), are world widely distributed in human population. After primary infection, BKV and JCV establish latency in kidneys and upper part of urinary tract. In seropositive healthy individuals asymptom
Autor:
Ivan Soldatovic, Aleksandar Jakovljevic, Miroslav Andric, Branka Popovic, Aleksandra Knezevic, Danijela Karalic, Jelena Milasin
Publikováno v:
Australian Endodontic Journal. 41:72-77
This study aimed to compare the levels of tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) between apical periodontitis lesions with different clinical and histological features. Based on clinical data and h
Publikováno v:
Archives of Biological Sciences, Vol 66, Iss 2, Pp 609-614 (2014)
BK virus (BKV) and JC virus (JCV) persist as latent infection in the kidneys. Reactivation of both viruses may be linked to immunodeficiency. The aims of this study were to determine the prevalence of BKV and JCV viruria and to evaluate the relations
Publikováno v:
Archives of Biological Sciences, Vol 66, Iss 2, Pp 573-577 (2014)
Cervical cancer incidence and mortality rates in Serbia are among the highest in Europe and data on Human papilloma virus (HPV) type distribution are scarce. The aim of this study was to determine the prevalence of HPV types in archival specimens of
Autor:
Tanja Jovanovic, Maja Cupic, Dragan Delic, Ana Banko, Jasmina Simonovic, Ivana Lazarevic, Danijela Karalic, Neda Svirtlih
Publikováno v:
Archives of Biological Sciences, Vol 66, Iss 2, Pp 601-608 (2014)
This study aimed to determine the prevalence and mutational patterns of lamivudine-resistant hepatitis B virus (HBV) strains in chronically infected Serbian patients. The study included 154 patients on long-term lamivudine monotherapy. Resistance-ass